BioTrace Medical's Series B Round

BioTrace Medical raised a round of funding on May 15, 2017. Investors include Emergent Medical Partners.

BioTrace Medical is dedicated to reinventing temporary pacing to improve patient outcomes and reduce hospital costs. BioTrace Medical's Tempo Lead incorporates innovations designed for secure and stab…

Articles about BioTrace Medical's Series B Round: